ACE2 and metabolic dysfunction-associated steatotic liver disease: As shown in Figures 1A–D, a qPCR analysis of the gene expression of RAS components revealed a marked down-regulation of ACE and AT1R, as well as an upregulation of ACE2 and Mas mRNA levels in the hepatic tissues of the liraglutide group compared with the NAFLD mice.